Search results
Ozempic, Wegovy May Protect Kidney Health, New Research Finds
Health via Yahoo News· 4 days agoOzempic and Wegovy may be able to significantly reduce the risk of kidney complications, heart...
Amino Acid Infusion Before Cardiac Surgery Reduced Acute Kidney Injury
MedPage Today· 2 days agoAn amino acid infusion reduced the occurrence of acute kidney injury (AKI) in adults undergoing...
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Benzinga· 4 days agoSAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted non-qualified stock
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and older with T2D. It was previously approved for such use in adults.
ProKidney (NASDAQ:PROK) Given New $6.00 Price Target at Jefferies Financial Group
ETF DAILY NEWS· 3 days agoProKidney (NASDAQ:PROK – Free Report) had its target price reduced by Jefferies Financial Group from $15.00 to $6.00 in a research note released on Monday, Benzinga reports. Jefferies Financial ...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
WTRF Wheeling· 6 days agoThe efficacy estimandi showed 51.8%, 62.8% and 73.3% of participants taking 5 mg, 10 mg and 15 mg, respectively, achieved an absence of MASH with no worsening of fibrosis ...
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and...
Benzinga· 4 days agoWINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. PROK ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic & ...
Pivotal advancement in the treatment of small cell lung cancer
KHGI Nebraska TV· 1 day ago1 in 16 Americans will face a lung cancer diagnosis in their lifetime.Lung cancer is a complex and...
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
Zacks via Yahoo Finance· 7 days agoEcolab’s shares have risen 18.7% year to date against the industry’s 20.1% decline. Ecolab has a...
Another potential indication for Mounjaro, Zepbound
Becker’s Hospital Review· 3 days agoThe trial results could precede another indication for the popular drugs. Mounjaro, a Type 2 diabetes medication, and Zepbound, a weight loss injection, are part of a booming class of drugs ...